Rosetta Genomics Unveils Two New Development-Stage Tests

The company also disclosed that its dispute with the US distributor of its three commercialized diagnostics, Prometheus Laboratories, is set to go before an arbitration panel shortly.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.